https://www.selleckchem.com/products/U0126.html
The need for regulatory review of infrared thermographs (IRTs) used on humans was removed in response to the unique circumstances of the SARS-CoV-2 pandemic (a.k.a., COVID-19). The market for these devices has since expanded considerably. This evaluation of IRT performance may have significant implications for febrility screening worldwide. Perform controlled nonhuman trials of IRT devices to identify and quantify deviations in the human temperature range. We compared IRT readings of a temperature-controlled non-human subject with one FDA
Like
Comment
Share
